+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Cardiovascular Surgery Devices Market Outlook to 2033 - Beating Heart Surgery Systems and Perfusion Disposables

  • PDF Icon

    Report

  • 54 Pages
  • August 2024
  • Region: United States
  • GlobalData
  • ID: 5999265
Description Jump to:
The “United States Cardiovascular Surgery Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Cardiovascular Surgery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Beating Heart Surgery Systems and Perfusion Disposables

The United States Cardiovascular Surgery Devices Market report provides key information and data on :

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Cardiovascular Surgery Devices Market.
  • Global corporate-level profiles of key companies operating within the United States Cardiovascular Surgery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Cardiovascular Surgery Devices is segmented as follows :

  • Beating Heart Surgery Systems
  • Perfusion Disposables

Reasons to Buy

The United States Cardiovascular Surgery Devices Market report helps you to develop :

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiovascular Surgery Devices Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiovascular Surgery Devices Market, United States
3.1 Cardiovascular Surgery Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Cardiovascular Surgery Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Cardiovascular Surgery Devices Market, United States, Average Price ($), 2018-2033
3.4 Cardiovascular Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Cardiovascular Surgery Devices Market
4.1 Getinge AB
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Abiomed Inc
4.3.1 Company Overview
4.4 LivaNova Plc
4.4.1 Company Overview
4.5 Medtronic Plc
4.5.1 Company Overview
4.6 Terumo Corp
4.6.1 Company Overview
4.7 Fresenius SE & Co KGaA
4.7.1 Company Overview
4.8 Edwards Lifesciences Corp
4.8.1 Company Overview
4.9 Braile Biomedica Ltda
4.9.1 Company Overview
4.10 Nipro Corp
4.10.1 Company Overview
4.11 Eurosets Srl
4.11.1 Company Overview
5 Cardiovascular Surgery Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 TriasMD Acquires Thousand Oaks Surgery Center
6.1.2 Hanger Acquires Fillauer
6.2 Debt Offerings
6.2.1 Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029
6.3 Private Equity
6.3.1 GTCR to Acquire Surmodics for Approximately USD627 Million
6.4 Venture Financing
6.4.1 Merit Medicine System Raises USD2 Million in Seed Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jun 26, 2024: MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
7.1.2 Feb 28, 2024: Integra LifeSciences Announces Leadership Transition Plan
7.1.3 Jan 11, 2024: James Kostek, DO Named New Medical Director of Babs Siperstein PROUD Center
7.1.4 Dec 18, 2023: Merit Medical Announces Process for Chief Executive Officer Succession Planning
7.1.5 Oct 13, 2023: Elos Medtech Notice to Attend the Extraordinary General Meeting
7.1.6 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President
7.2 Financial Announcements
7.2.1 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
7.2.2 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
7.2.3 Apr 25, 2024: Edwards Lifesciences Reports First Quarter Results
7.2.4 Feb 28, 2024: Merit Medical Introduces 'Continued Growth Initiatives' Program and Financial Targets for Three-Year Period Ending December 31, 2026
7.2.5 Jan 16, 2024: Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
7.2.6 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
7.2.7 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.2.8 Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
7.2.9 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
7.2.10 Oct 16, 2023: MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30
7.3 Government and Public Interest
7.3.1 Jun 01, 2024: Typhoid Fever Vaccine “Tyfim V-I Injection Syringe” Information Regarding Obtaining Manufacturing and Sales Approval
7.3.2 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
7.3.3 Nov 08, 2023: MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid Distribution in Europe
7.3.4 Aug 29, 2023: SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023
7.3.5 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
7.3.6 Aug 11, 2023: W. L. Gore & Associates to Present New Mosa Paper At Gvsets Conference
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2018-2033
Table 5: Beating Heart Surgery Systems Market, United States, Volume (Units), 2018-2033
Table 6: Perfusion Disposables Market, United States, Volume (Units), 2018-2033
Table 7: Cardiovascular Surgery Devices Market, United States, Average Price ($), 2018-2033
Table 8: Cardiovascular Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 9: Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 10: Cardiovascular Surgery Devices Market Pipeline Products
Table 11: TriasMD Acquires Thousand Oaks Surgery Center
Table 12: Hanger Acquires Fillauer
Table 13: Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029
Table 14: GTCR to Acquire Surmodics for Approximately USD627 Million
Table 15: Merit Medicine System Raises USD2 Million in Seed Financing
Table 16: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2018-2033
Figure 5: Beating Heart Surgery Systems Market, United States, Volume (Units), 2018-2033
Figure 6: Perfusion Disposables Market, United States, Volume (Units), 2018-2033
Figure 7: Cardiovascular Surgery Devices Market, United States, Company Share (%) 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Terumo Corp
  • Abbott Laboratories
  • LivaNova PLC
  • Getinge AB

Related Topics

Related Reports

North America Cardiovascular Surgery Devices Market Outlook to 2033 - Beating Heart Surgery Systems and Perfusion Disposables - Product Image

North America Cardiovascular Surgery Devices Market Outlook to 2033 - Beating Heart Surgery Systems and Perfusion Disposables

  • Report
  • 93 Pages
  • North America
From
Beating Heart Surgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 - Product Image

Beating Heart Surgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

  • Report
  • Global
From
Cardiovascular Surgery Devices - Global Strategic Business Report - Product Image

Cardiovascular Surgery Devices - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry Trends, Growth, Insight, Top Companies Analysis - Product Image

Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry Trends, Growth, Insight, Top Companies Analysis

  • Report
  • 200 Pages
  • Global
From
Cardiovascular Surgery Devices Market by Product Type, Procedure Type, End User - Global Forecast 2025-2030 - Product Image

Cardiovascular Surgery Devices Market by Product Type, Procedure Type, End User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From

About the Cardiovascular Surgical Device Market

The Cardiovascular Surgical Device market is a subset of the larger Cardiovascular Devices market. It includes a range of products used in the diagnosis and treatment of cardiovascular diseases, such as heart valves, stents, and catheters. These devices are used to diagnose and treat a variety of cardiovascular conditions, including coronary artery disease, heart failure, and arrhythmias. They are also used to perform minimally invasive procedures, such as angioplasty and bypass surgery. The Cardiovascular Surgical Device market is highly competitive, with a number of major players offering a wide range of products. Companies in the market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.